The store will not work correctly when cookies are disabled.
Methyl 4-(3-Acetyl-4-hydroxy-5-oxo-1-phenethyl-2,5-dihydro-1Hpyrrol-2-yl)benzoate
ID: ALA3237303
PubChem CID: 73335991
Max Phase: Preclinical
Molecular Formula: C22H21NO5
Molecular Weight: 379.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ccc(C2C(C(C)=O)=C(O)C(=O)N2CCc2ccccc2)cc1
Standard InChI: InChI=1S/C22H21NO5/c1-14(24)18-19(16-8-10-17(11-9-16)22(27)28-2)23(21(26)20(18)25)13-12-15-6-4-3-5-7-15/h3-11,19,25H,12-13H2,1-2H3
Standard InChI Key: CPBYAEZNUJSDLB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
4.3889 -14.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1056 -13.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1099 -13.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8265 -12.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5388 -13.1617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5345 -13.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8179 -14.3954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6766 -13.9717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4278 -15.2120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9267 -13.2323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2554 -12.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5037 -11.9662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3287 -11.9595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5901 -12.7419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9335 -14.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6513 -14.4639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6582 -15.2889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3760 -15.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3827 -16.5205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6718 -16.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9539 -16.5323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9471 -15.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3768 -12.9904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8081 -11.2881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0133 -11.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1936 -11.3958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3427 -10.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1609 -15.5904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
10 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
10 15 1 0
14 23 2 0
13 24 1 0
25 26 2 0
25 27 1 0
12 25 1 0
5 11 1 0
9 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.41 | Molecular Weight (Monoisotopic): 379.1420 | AlogP: 3.00 | #Rotatable Bonds: 6 |
Polar Surface Area: 83.91 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.66 | CX Basic pKa: ┄ | CX LogP: 2.84 | CX LogD: 2.84 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.78 | Np Likeness Score: -0.73 |
References
1. Zimmerman SS, Khatri A, Garnier-Amblard EC, Mullasseril P, Kurtkaya NL, Gyoneva S, Hansen KB, Traynelis SF, Liotta DC.. (2014) Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators., 57 (6): [PMID:24512267] [10.1021/jm401695d] |